Head-to-head comparisons of Labisan against the major cold sore treatments. The honest case for each, including where Labisan loses, and the 12-month cost arithmetic against the pharmacy bundle.
Labisan's 5-active topical (22 percent zinc, 5 percent graviola, manuka, oregano, menthol) plus SPF 20 reduces outbreak frequency from 6 per year to 1 over 12 months. Abreva's single docosanol active reduces outbreak duration only by 1 to 2 days, requires 5 daily applications, an...
Labisan delivers 5 antiviral actives, SPF 20, and a clinical 6-to-1 outbreak reduction over 12 months with no prescription, no resistance pathway, no renal monitoring. Zovirax (acyclovir 5 percent cream) requires prescription in EU and most markets, hits one mechanism (DNA polyme...
Labisan delivers 5 active antiviral layers plus 22 percent zinc oxide SPF and a clinical 6-to-1 outbreak reduction over 12 months. Compeed is a single-mechanism hydrocolloid patch with no antiviral, no SPF, and a 15 to 45 minute fail point in water or sweat. The numbers settle th...
Labisan delivers 5 antiviral actives, 22 percent zinc oxide SPF 20, Austrian EU GMP pharma-grade manufacturing, and a clinical 6-to-1 outbreak reduction over 12 months. Carmex Cold Sore Treatment is a $5 drugstore moisturizer with salicylic acid, camphor, and menthol; zero antivi...
If you have 4 to 6 HSV-1 outbreaks per year, the standard pharmacy path costs more than the Labisan dual-protocol bundle. This post walks through the actual numbers: per-outbreak cream, prescription antiviral, repeat visits, and the often-ignored cost of lost work hours. The bund...
